Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China flag China · Delayed Price · Currency is CNY
7.64
+0.45 (6.26%)
At close: Sep 1, 2025

SHA:688373 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
Cash & Equivalents
269.12386.26166.31151.09145.52226.51
Upgrade
Trading Asset Securities
253.18207.36786.981,119326.36410.45
Upgrade
Cash & Short-Term Investments
522.29593.62953.31,270471.88636.96
Upgrade
Cash Growth
-32.77%-37.73%-24.95%169.17%-25.92%1110.55%
Upgrade
Accounts Receivable
36.2531.8821.9811.11.42-
Upgrade
Other Receivables
23.9821.020.190.3404.93
Upgrade
Receivables
60.2352.922.1711.441.424.93
Upgrade
Inventory
50.5252.9437.5221.8911.015.61
Upgrade
Other Current Assets
48.8349.2141.2767.0125.2914.5
Upgrade
Total Current Assets
681.88748.661,0541,371509.59662
Upgrade
Property, Plant & Equipment
68.375.886.2197.46122.81.02
Upgrade
Other Intangible Assets
1.241.681.932.190.840.13
Upgrade
Long-Term Deferred Charges
17.5719.121.7522.681.832.65
Upgrade
Other Long-Term Assets
3.913.894.424.5413.483.15
Upgrade
Total Assets
772.9849.131,1691,497648.54668.94
Upgrade
Accounts Payable
13.8226.2111.1310.851.91-
Upgrade
Accrued Expenses
87.6478.6394.5137.4129.4526.25
Upgrade
Short-Term Debt
55-48.7550.086.53
Upgrade
Current Portion of Long-Term Debt
136.3589.2314.1510.1--
Upgrade
Current Portion of Leases
11.6811.5110.386.4711.04-
Upgrade
Current Income Taxes Payable
--4.41---
Upgrade
Current Unearned Revenue
--0.13---
Upgrade
Other Current Liabilities
1.081.711.931.521.710.44
Upgrade
Total Current Liabilities
255.58212.3136.65115.1194.1933.22
Upgrade
Long-Term Debt
135.53122.94114.9670--
Upgrade
Long-Term Leases
66.6773.1881.794.8999.87-
Upgrade
Long-Term Unearned Revenue
1.751.751.253.116.115.5
Upgrade
Total Liabilities
459.53410.16334.56283.1210.1748.72
Upgrade
Common Stock
655.61655.61655.21655.21525.21525.21
Upgrade
Additional Paid-In Capital
1,5861,5711,5321,495636.77591.38
Upgrade
Retained Earnings
-1,943-1,805-1,364-942.85-722.55-496.28
Upgrade
Comprehensive Income & Other
14.9117.0810.917.19-1.06-0.09
Upgrade
Shareholders' Equity
313.38438.968341,214438.37620.23
Upgrade
Total Liabilities & Equity
772.9849.131,1691,497648.54668.94
Upgrade
Total Debt
355.24301.86221.19230.21160.996.53
Upgrade
Net Cash (Debt)
167.06291.76732.111,040310.88630.43
Upgrade
Net Cash Growth
-67.09%-60.15%-29.60%234.52%-50.69%-
Upgrade
Net Cash Per Share
0.250.451.121.790.592.47
Upgrade
Filing Date Shares Outstanding
655.61655.61655.21655.21525.21525.21
Upgrade
Total Common Shares Outstanding
655.61655.61655.21655.21525.21525.21
Upgrade
Working Capital
426.3536.37917.611,255415.39628.78
Upgrade
Book Value Per Share
0.480.671.271.850.831.18
Upgrade
Tangible Book Value
312.13437.28832.071,212437.53620.09
Upgrade
Tangible Book Value Per Share
0.480.671.271.850.831.18
Upgrade
Machinery
14.6514.4114.1811.756.013.85
Upgrade
Construction In Progress
----15.650.35
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.